Growth hormone therapy can repair growth retardation in patients with spondyloepiphyseal dysplasia, Kondo-Fu type; however, more evidence of such patient cases is required to support this hypothesis. This evidence concerns the gene GH1 and spondyloepiphyseal dysplasia.